ABOUT THE AUTHOR
Alan Berch Hollingsworth, M.D,

Alan Berch Hollingsworth, MD is a breast cancer specialist with a focus on predictive medicine – that is, risk analysis and genetic testing to identify those individuals at high risk who are more likely to benefit from available interventions.  He received his M.D. with Distinction in 1975 from the University of Oklahoma where he was also named First Vice-president of Alpha Omega Alpha Honor Medical Society.  During his surgical training at OU, he spent one year as a fellow in anatomic pathology at UCLA (1977-78) during the launch of the concept of “premalignant” changes in benign breast biopsies.  Almost four decades later, his interest in identifying individuals at high risk for breast cancer while outlining strategies to lower risk, or better assure early detection through multi-modality imaging, now occupies his entire medical practice. READ MORE